SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Rossari Biotech - Quaterly Results

29 Jul 2023 Evaluate
The company witnessed a 10.53% growth in the revenue at Rs. 2583.42 millions for the quarter ended June 2023 as compared to Rs. 2337.36 millions during the year-ago period.Net Profit recorded in the quarter ended June 2023 rise to 40.28% to Rs. 215.57  millions  compared to R. 153.67 millions in corresponding previous quarter.OP of the company witnessed a marginal growth to 364.73 millions from 276.90 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202306 202206 % Var 202306 202206 % Var 202303 202203 % Var
Sales 2583.42 2337.36 10.53 2583.42 2337.36 10.53 9751.72 10728.44 -9.10
Other Income 13.36 6.29 112.40 13.36 6.29 112.40 35.98 127.00 -71.67
PBIDT 364.73 276.90 31.72 364.73 276.90 31.72 1262.46 1354.93 -6.82
Interest 18.75 6.04 210.43 18.75 6.04 210.43 46.18 25.45 81.45
PBDT 345.98 270.86 27.73 345.98 270.86 27.73 1216.28 1329.48 -8.51
Depreciation 55.10 62.10 -11.27 55.10 62.10 -11.27 259.83 262.68 -1.08
PBT 290.88 208.76 39.34 290.88 208.76 39.34 956.45 1066.80 -10.34
TAX 75.31 55.09 36.70 75.31 55.09 36.70 242.55 272.06 -10.85
Deferred Tax -3.25 -3.10 4.84 -3.25 -3.10 4.84 -17.11 -15.09 13.39
PAT 215.57 153.67 40.28 215.57 153.67 40.28 713.90 794.74 -10.17
Equity 110.31 110.11 0.18 110.31 110.11 0.18 110.31 110.11 0.18
PBIDTM(%) 14.12 11.85 19.17 14.12 11.85 19.17 12.95 12.63 2.51

Rossari Biotech Share Price

483.60 4.85 (1.01%)
04-May-2026 11:29 View Price Chart
Peers
Company Name CMP
BASF India 3709.95
Tata Chemicals 820.50
SRF 2558.20
Pidilite Inds. 1383.70
Deepak Nitrite 1736.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×